Distinct clinical phenotypes for Crohn’s disease derived from patient surveys

BMC Gastroenterology

Table 5 Significance of differentiated drug responses in CD subtypes

Drug	p value	Odd ratio (CD1:CD2)	Confidence interval
Drug	p value	Odd ratio (CD1:CD2)	2.5%	97.5%
Salicylates	0.0322	1.372	1.027	1.832
Antibiotics	0.2074	0.783	0.534	1.146
Corticosteroids	0.0897	0.745	0.533	1.047
Immunosuppressants	0.4940	0.850	0.531	1.353
Adalimumab	0.0135	1.742	1.119	2.764
Infliximab	0.0259	1.695	1.064	2.781

At a significance level 0.05, CD1 patients gave more positive response (effective) to adalimumab, infliximab and salicylates, compared with CD2. At a significance level 0.1, CD2 patients gave more positive response to corticosteroids, compared with those in CD1. The odd ration of positive response in CD1 compared with CD2 are in column 3

ISSN: 1471-230X